Lev Gertsik
Los Angeles Clinical Trials(US)
Publications by Year
Research Areas
Bipolar Disorder and Treatment, Treatment of Major Depression, Receptor Mechanisms and Signaling, Phosphodiesterase function and regulation, Neurotransmitter Receptor Influence on Behavior
Most-Cited Works
- → Omega-3 Fatty Acid Augmentation of Citalopram Treatment for Patients With Major Depressive Disorder(2011)162 cited
- → AZD8529, a positive allosteric modulator at the mGluR2 receptor, does not improve symptoms in schizophrenia: A proof of principle study(2016)84 cited
- → Examination of Org 26576, an AMPA receptor positive allosteric modulator, in patients diagnosed with major depressive disorder: an exploratory, randomized, double-blind, placebo-controlled trial(2012)70 cited
- → A Phase 1B, randomized, double blind, placebo controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patients(2015)42 cited
- → Effect of treatment with bupropion on EEG sleep: relationship to antidepressant response(2004)39 cited
- → A Proof-of-Concept Study Evaluating the Phosphodiesterase 10A Inhibitor PF-02545920 in the Adjunctive Treatment of Suboptimally Controlled Symptoms of Schizophrenia(2019)34 cited
- → Maximum Tolerated Dose Evaluation of the AMPA Modulator Org 26576 in Healthy Volunteers and Depressed Patients(2012)22 cited
- → A Randomized Multiple Dose Pharmacokinetic Study of a Novel PDE10A Inhibitor TAK-063 in Subjects with Stable Schizophrenia and Japanese Subjects and Modeling of Exposure Relationships to Adverse Events(2017)19 cited
- → Phase 1 randomized study on the safety, tolerability, and pharmacodynamic cognitive and electrophysiological effects of a dopamine D1 receptor positive allosteric modulator in patients with schizophrenia(2020)19 cited
- → Open-Label, Randomized, Parallel-Group Controlled Clinical Trial of Massage for Treatment of Depression in HIV-Infected Subjects(2012)18 cited